Biocon arm secures USFDA approval for Everolimus Tablets for prophylaxis of organ rejection in adult patients Ruchika Sharma11 April 2025 12:30 PM ISTBangalore: Biocon Limited has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received approval...
Biocon Biologics gets USFDA nod for cancer drug Jobevne Ruchika Sharma10 April 2025 12:39 PM ISTBengaluru: Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, has announced that the U.S. Food and Drug Administration (U.S. FDA) has...
Biocon to raise up to Rs 600 crore Ruchika Sharma7 April 2025 4:15 PM ISTBangalore: In a recent BSE filing, Biocon has said that its Board of Directors has approved to raise up to Rs 600 crore in one or...
Biocon Pharma gets USFDA approval for BP-raising injection in adults with acute hypotension Ruchika Sharma24 March 2025 11:30 AM ISTBengaluru: Biocon has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received approval from the...
Phase 3 study comparing Yesintek with Stelara in adult patients with chronic plaque psoriasis shows positive results: Biocon Biologics Ruchika Sharma8 March 2025 1:30 PM ISTBengaluru: BioconBiologics Ltd., a fully integrated global biosimilars company and subsidiary of Biocon Ltd. has announced the successful results...
Biocon Biologics, Civica join hands to expand Insulin Aspart access in US Ruchika Sharma7 March 2025 11:30 AM ISTCivica will commercialize the medicine for patients in the United States, after completion of development work and clinical trials.
Biocon arm gets USFDA nod for cancer, deep vein thrombosis drugs Ruchika Sharma5 March 2025 11:30 AM ISTBangalore: Biocon Limited has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received final approvals...
Biocon launches Liraglutide for diabetes, obesity in UK Ruchika Sharma28 Feb 2025 8:26 PM ISTBengaluru: Biocon Limited, an innovation-led global biopharmaceutical company, has announced the launch of its GLP-1 peptide, Liraglutide, for...
Biocon Biologics unveils Yesintek biosimilar to Stelara in US Ruchika Sharma25 Feb 2025 12:31 PM ISTYESINTEK will be available in all the same formulations currently provided by Stelara.
Biocon Biologics Yesintek gets European Commission approval for plaque psoriasis, psoriatic arthritis Ruchika Sharma18 Feb 2025 3:42 PM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced that the European...
Biocon, Equillium announce positive data from Phase 2 Study evaluating Itolizumab for Ulcerative Colitis Ruchika Sharma7 Feb 2025 11:30 AM ISTBengaluru: Equillium, Inc., a clinical-stage biotechnology company and Biocon Limited, an innovation-led global biopharmaceutical company, have...
Biocon likely to list key biosimilars business by March 2026 Ruchika Sharma1 Feb 2025 2:30 PM ISTHyderabad: Biopharma major Biocon plans to introduce five new biosimilars in the United States in the new fiscal year, starting in April and is likely...
